Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
OP ›
OPRADICA
Trademark search for:
OPRADICA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-12-31 — Application filed
2016-01-04 — Application filed
2016-01-11 — Application filed
2016-01-11 — Teas petition to director-make special-received
2016-01-12 — Teas change of owner address received
2016-01-12 — Applicant/correspondence changes (non-responsive) entered
2016-01-25 — Assigned to petition staff
2016-01-27 — Petition to director - make special - denied
2016-02-11 — Assigned to examiner
2016-02-12 — Suspension letter written
2016-02-12 — Letter of suspension e-mailed
2016-02-12 — Notification of letter of suspension e-mailed
2016-02-26 — Suspension letter written
2016-02-26 — Letter of suspension e-mailed
2016-02-26 — Notification of letter of suspension e-mailed
2016-04-07 — Teas response to suspension inquiry received
2016-04-07 — Correspondence received in law office
2016-04-08 — Teas/email correspondence entered
2016-05-02 — Assigned to lie
2016-05-02 — Data modification completed
2016-05-03 — Approved for pub - principal register
2016-05-03 — Law office publication review completed
2016-05-18 — Notification of notice of publication e-mailed
2016-06-07 — Published for opposition
2016-06-07 — Official gazette publication confirmation e-mailed
2016-08-02 — Noa e-mailed - sou required from applicant
2017-01-25 — Sou teas extension received
2017-01-25 — Sou extension 1 filed
2017-01-25 — Sou extension 1 granted
2017-01-27 — Notice of approval of extension request e-mailed
2017-09-04 — Application abandoned
2017-09-04 — Final status recorded
2017-09-05 — Application abandoned
Owner Information
Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
Correspondent
JEFFREY L. COSTELLIA NIXON PEABODY LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
